SVALX | VVIAX | SVALX / VVIAX | |
Total Expense Ratio | 0.79 | 0.05 | 1,580% |
Annual Report Gross Expense Ratio | 0.85 | 0.05 | 1,700% |
Fund Existence | 9 years | 25 years | - |
Gain YTD | 11.890 | 9.746 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.67B | 208B | 4% |
Annual Yield % from dividends | 3.22 | 2.08 | 155% |
Returns for 1 year | 4.96 | 4.64 | 107% |
Returns for 3 years | 29.86 | 43.00 | 69% |
Returns for 5 years | 66.46 | 71.80 | 93% |
Returns for 10 years | N/A | 129.42 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 73.75 | 0.46 | +0.63% |
Janus Henderson Global Life Sciences A | |||
GMVCX | 15.68 | 0.03 | +0.19% |
Goldman Sachs Small/Mid Cap Equity C | |||
VDIPX | 30.50 | 0.03 | +0.10% |
Vanguard Developed Markets Index Ins Pls | |||
SCOBX | 46.28 | -0.03 | -0.06% |
DWS International Growth S | |||
TAIWX | 13.94 | -0.09 | -0.64% |
Nuveen Quant Intl Small Cap Eq W |